Learn more about MDS at http://www.YouAndMDS.com
MDS expert Rafael Bejar, MD, PhD, shares how the type of genetic mutation present in MDS can make an allogeneic stem cell transplant, or bone marrow transplant, more desirable – for example, in highrisk myelodysplastic syndromes (MDS). Knowing which genetic mutations are present can also help doctors and patients decide if alternatives such as experimental therapies or myelodysplastic syndromes (MDS) are better options if the mutation makes relapse more likely.